F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on review of policies and clinical records, as well as staff interviews, it was determined that the
facility failed to ensure the accountability of controlled medications (drugs with the potential to be abused)
for two of four residents reviewed (Residents 3, 4).
Findings include:
A facility policy for controlled substances, dated August 27, 2024, indicated that the charge nurse on duty
maintains the keys to controlled substance containers. Controlled medications are to be wasted or disposed
of in the presence of the nurse and a witness who also signs the disposition sheet.
A quarterly Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and
care needs) for Resident 3, dated August 9, 2024, revealed that the resident was cognitively impaired, had
pain, and received an opioid (a controlled pain medication).
Current physician's orders for Resident 3, included an order for the resident to receive 5 milligrams (mg) of
oxycodone every eight hours as needed for pain rated between 5-10 (a numeric scale with 0 representing
no pain and 10 representing the worst pain possible).
Review of the controlled drug record (a form that accounts for each tablet/pill/dose of a controlled drug) for
Resident 3 for August and September 2024 revealed that staff signed out a dose of oxycodone for
administration to the resident on August 23, 2024, at 3:00 p.m. and September 21, 2024, at 11:40 p.m.
However, there was no documented evidence in the resident's Medication Administration Record (MAR) or
clinical record to indicate that the oxycodone was administered to the resident on the above listed dates
and times.
A quarterly Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and
care needs) for Resident 4, dated August 9, 2024, revealed that the resident was cognitively impaired, had
pain, and received an opioid.
Physician's orders for Resident 4, dated August 17, 2024, included an order for the resident to receive 5 mg
of oxycodone every 4 hours as need for pain that was rated between 5-10.
Review of the controlled drug record for Resident 3 for August 2024 revealed that staff signed out a dose of
oxycodone 10 mg for administration to the resident on August 23, 2024, at 8:12 a.m., 12:37 p.m., and 4:54
p.m. However, there was no documented evidence in the resident's MAR or clinical record to indicate that
the 5 mg of oxycodone was administered as ordered and the other 5 mg was wasted by two licensed
nurses.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
395241
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395241
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/23/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Hilltop Healthcare and Rehabilitation Center
700 S. Cayuga Avenue
Altoona, PA 16602
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Interview with the Director of Nursing on September 12, 2024, at 12:15 p.m. confirmed that there was no
documented evidence in Resident 3's and 4's clinical records to indicate that the signed-out doses of
oxycodone were administered as ordered to the residents on the above-mentioned dates and times.
28 Pa. Code 211.9(a)(1) Pharmacy Services.
Residents Affected - Few
28 Pa. Code 211.12(d)(1)(3)(5) Nursing Services.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395241
If continuation sheet
Page 2 of 2